Scott R. Ward - 25 Nov 2024 Form 3 Insider Report for InspireMD, Inc. (NSPR)

Role
Director
Signature
/s/ Craig Shore, Attorney-in-Fact
Issuer symbol
NSPR
Transactions as of
25 Nov 2024
Net transactions value
$0
Form type
3
Filing time
27 Nov 2024, 16:15:25 UTC
Previous filing
27 Apr 2023
Next filing
10 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NSPR Common Stock 43,548 25 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NSPR Options to purchase common stock (right to buy) 25 Nov 2024 Common Stock 16,647 $2.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable on November 25, 2025, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2025 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2025 annual meeting of stockholders, any unvested shares of restricted stock will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable).
F2 The options vest and become exercisable on November 25, 2025, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2025 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2025 annual meeting of stockholders, any unvested options will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable).

Remarks:

Exhibit 24.1: Power of Attorney